Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Deleted a MedlinePlus Genetics topic related to Prostate cancer, removing it from the page's core topics.
    Difference
    0.2%
    Check dated 2025-10-13T12:05:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:59:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Prostate cancer and updated the revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T04:30:53.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic on Prostate cancer, reducing genetic-disease content and potentially narrowing the scope of informational topics available on the page.
    Difference
    0.2%
    Check dated 2025-09-22T01:44:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page version has been updated from v3.0.1 to v3.0.2. The 'Back to Top' control has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T22:12:57.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Prostate cancer under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T19:20:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.